# Cyclophosphamide

NDC: 65219-133
Generic name: cyclophosphamide
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS, ORAL
Marketing started: 20231117

FDA application: ANDA204555

## Active ingredients

- CYCLOPHOSPHAMIDE: 2 g/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31986d36-a1bf-4903-93a4-ce7386241ba1